Cannopeia

Company Overview

Snapshot

Founded in July 2019 by Jimmy Levy and Bernard Juster, Cannopeia operated with 1–10 employees. The company secured one funding round from one investor, Btomorrow Ventures, before ceasing operations in December 2023.

Business overview

Cannopeia developed proprietary technologies for cannabis vaping and formulation, focusing on safe and effective use. Its devices allowed medical and non-medical cannabis users to manage consumption by controlling dosage and mixing formulations on demand. Integrating sensors and instruments, the technology gathered data on cannabis treatment effects and efficacy, aiming to serve as a personal digital cannabis coach. The company operated in the Health Tech & Life Sciences sector, specifically within Medical Cannabis, targeting consumers and patients.

Company Intelligence Q&A

What is Cannopeia's primary focus?

Cannopeia focuses on developing proprietary cannabis vaping and formulation technologies designed to ensure the safe and effective use of cannabis, allowing users to manage dosage and mix formulations on demand.

When was Cannopeia founded?

Cannopeia was founded in July 2019.

Who are the founders of Cannopeia?

Cannopeia was founded by Jimmy Levy and Bernard Juster.

What is the current status of Cannopeia?

Cannopeia is currently non-active, having ceased operations in December 2023.